Diabetes, diabetes treatment and breast cancer prognosis

Breast Cancer Research and Treatment

Volumn 148, Issue 1, 2014, Pages 153-162

  Luo, Juhua ^a   Virnig, Beth ^b   Hendryx, Michael ^a   Wen, Sijin ^c   Chelebowski, Rowan ^d,e   Chen, Chu ^f   Rohan, Tomas ^g   Tinker, Lesley ^f   Wactawski Wende, Jean ^h   Lessin, Lawrence ⁱ   Margolis, Karen ^j  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e TORRANCE MEMORIAL MEDICAL CENTER   (United States)

^f USA   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^j HEALTHPARTNERS INSTITUTE   (United States)

more..

Author keywords

Breast cancer; Diabetes; Diabetes treatment; Prognosis

Indexed keywords

ESTROGEN; GESTAGEN; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; COHORT ANALYSIS; COMORBIDITY; CONTAINER; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; BREAST TUMOR; COMPLICATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; BREAST NEOPLASMS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84921937722     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3146-9     Document Type: Article

References (40)

1. The Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19:61–109
2. Women’s Health Initiative. https://www.whi.org/about/SitePages/About%20WHI.aspx
3. Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS (2003) Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat oncol 13:346–356. doi:10.1016/S1053-4296(03)00026-2
4. Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM (2012) Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer 118:1202–1211. doi:10.1002/cncr.26439
5. Ben Sahra I, Regazzetti C, Robert G, Laurent K, Le Marchand-Brustel Y, Auberger P, Tanti JF, Giorgetti-Peraldi S, Bost F (2011) Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res 71:4366–4372. doi:10.1158/0008-5472.CAN-10-1769
6. Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, Fairley LL, Boniol M, Zheng T, Zhang Y, Pasterk M, Smans M, Curado MP, Mullie P, Gandini S, Bota M, Bolli GB, Rosenstock J, Autier P (2012) Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. doi:10.1038/bjc.2012.414
7. Chen WW, Shao YY, Shau WY, Lin ZZ, Lu YS, Chen HM, Kuo RN, Cheng AL, Lai MS (2012) The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist 17:485–491. doi:10.1634/theoncologist.2011-0412
8. Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, Kaklamani VG, Vitolins M, Wallace R, Gunter M, Phillips LS, Strickler H, Margolis K, Euhus DM (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 30:2844–2852. doi:10.1200/JCO.2011.39.7505
9. Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD (2012) The association of diabetes with breast cancer incidence and mortality in the Long Island breast cancer study project. Cancer Causes Control 23:1193–1203. doi:10.1007/s10552-012-9989-7
10. Col NF, Ochs L, Springmann V, Aragaki AK, Chlebowski RT (2012) Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Res Tr 135:639–646. doi:10.1007/s10549-012-2170-x
11. Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL (2012) Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 35:299–304. doi:10.2337/dc11-1313
12. Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP (2011) Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol 29:54–60. doi:10.1200/JCO.2010.29.3183
13. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
14. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD (1999) A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care 37(601–614):18
15. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685. doi:10.2337/dc10-0666
16. Hou G, Zhang S, Zhang X, Wang P, Hao X, Zhang J (2013) Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes. Breast Cancer Res Tr 137:807–816. doi:10.1007/s10549-012-2404-y
17. Jackson JM, Defor TA, Crain AL, Kerby T, Strayer L, Lewis CE, Whitlock E, Williams S, Bonds DE, Vitolins MZ, Rodabough RJ, Margolis KL (2013) Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies. J Clin Epidemiol 66:349–350. doi:10.1016/j.jclinepi.2012.01.013
18. Kaplan MA, Pekkolay Z, Kucukoner M, Inal A, Urakci Z, Ertugrul H, Akdogan R, Firat U, Yildiz I, Isikdogan A (2012) Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Med Oncol 29:1576–1580. doi:10.1007/s12032-011-0109-4
19. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862. doi:10.1002/ijc.22717
20. Lega IC, Austin PC, Gruneir A, Goodwin PJ, Rochon PA, Lipscombe LL (2013) Association Between Metformin Therapy and Mortality After Breast Cancer A population-based study. Diabetes Care 36:3018–3026. doi:10.2337/Dc12-2535
21. Liao S, Li J, Wei W, Wang L, Zhang Y, Li J, Wang C, Sun S (2011) Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pacific J Cancer Prevention 12:1061–1065
22. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Tr 109:389–395. doi:10.1007/s10549-007-9654-0
23. Lipscombe LL, Hux JE, Booth GL (2005) Reduced screening mammography among women with diabetes. Arch Intern Med 165:2090–2095
24. Liu XD, Ji JG, Sundquist K, Sundquist J, Hemminki K (2012) The impact of type 2 diabetes mellitus on cancer-specific survival a follow-up study in Sweden. Cancer 118:1353–1361. doi:10.1002/Cncr.26420
25. Luo J, Lin HC, He K, Hendryx M (2014) Diabetes and prognosis in older persons with colorectal cancer. Br J Cancer 110:1847–1854. doi:10.1038/bjc.2014.68
26. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, Simin L, Robinson JG, Safford MM, Tinker LT, Phillips LS (2008) Validity of diabetes self-reports in the Women’s Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5:240–247. doi:10.1177/1740774508091749
27. McBean AM, Yu XH (2007) The underuse of screening services among elderly women with diabetes. Diabetes Care 30:1466–1472. doi:10.2337/Dc06-2233
28. Morss AS, Edelman ER (2007) Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem 282:14635–14644. doi:10.1074/jbc.M608565200
29. Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Derr RL, Brancati FL, Wolff AC (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29:40–46. doi:10.1200/JCO.2009.27.3011
30. Peeters PJ, Bazelier MT, Vestergaard P, Leufkens HG, Schmidt MK, de Vries F, De Bruin ML (2013) Use of metformin and survival of diabetic women with breast cancer. Current drug safety 8:357–363
31. Putter H, Fiocco M, Geskus RB (2007) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26:2389–2430. doi:10.1002/sim.2712
32. Richardson LC, Pollack LA (2005) Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2:48–53. doi:10.1038/ncponc0062
33. Sachdev D, Yee D (2001) The IGF system and breast cancer. Endocr Relat Cancer 8:197–209
34. Schrauder MG, Fasching PA, Haberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR (2010) Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol. doi:10.1007/s00432-010-0960-2
35. Seidman A, Hudis C, Pierri MK, Shak S, Paton V, Ashby M, Murphy M, Stewart SJ, Keefe D (2002) Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 20:1215–1221
36. Serrano C, Cortes J, De Mattos-Arruda L, Bellet M, Gomez P, Saura C, Perez J, Vidal M, Munoz-Couselo E, Carreras MJ, Sanchez-Olle G, Tabernero J, Baselga J, Di Cosimo S (2012) Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncol 23:897–902. doi:10.1093/annonc/mdr348
37. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009) Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170–2176. doi:10.1200/JCO.2008.17.5935
38. Wolbers M, Koller MT, Witteman JC, Steyerberg EW (2009) Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20:555–561. doi:10.1097/EDE.0b013e3181a39056
39. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111. doi:10.1016/S1470-2045(05)01736-5
40. Xiao Y, Zhang S, Hou G, Zhang X, Hao X, Zhang J (2013) Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer. Tumour Biol. doi:10.1007/s13277-013-1270-5